Synthesis and preclinical characterization of 1-(60-deoxy-60-[18F]fluoro-b-D-allofuranosyl)-2-nitroimidazole (b-60-[18F]FAZAL) as a positron emission tomography radiotracer to assess tumor hypoxia

Thomas Wanek; Katharina Kreis; Petra Krizkova; Anna Schweifer; Christoph Denk; Johann Stanek; Severin Mairinger; Thomas Filip; Michael Sauberer; Patricia Alexandra Edelhofer; Alexander Traxl; Viktoria Muchitsch; Kurt Mereiter; Friedrich Hammerschmidt; Carol Cass; Vijaya Damaraju; Oliver Langer; Claudia Kuntner

Synthesis and preclinical characterization of 1-(60-deoxy-60-[18F]fluoro-b-D-allofuranosyl)-2-nitroimidazole (b-60-[18F]FAZAL) as a positron emission tomography radiotracer to assess tumor hypoxia

Thomas Wanek, Katharina Kreis, Petra Krizkova, Anna Schweifer, Christoph Denk, Johann Stanek, Severin Mairinger, Thomas Filip, Michael Sauberer, Patricia Alexandra Edelhofer, Alexander Traxl, Viktoria Muchitsch, Kurt Mereiter, Friedrich Hammerschmidt, Carol Cass, Vijaya Damaraju, Oliver Langer, Claudia Kuntner

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	5326-5339
Number of pages	14
Journal	Bioorganic and Medicinal Chemistry
Publication status	Published - 2016

Research Field

Former Research Field - Health and Bioresources

Cite this

Wanek, T., Kreis, K., Krizkova, P., Schweifer, A., Denk, C., Stanek, J., Mairinger, S., Filip, T., Sauberer, M., Edelhofer, P. A., Traxl, A., Muchitsch, V., Mereiter, K., Hammerschmidt, F., Cass, C., Damaraju, V., Langer, O., & Kuntner, C. (2016). Synthesis and preclinical characterization of 1-(60-deoxy-60-[18F]fluoro-b-D-allofuranosyl)-2-nitroimidazole (b-60-[18F]FAZAL) as a positron emission tomography radiotracer to assess tumor hypoxia. Bioorganic and Medicinal Chemistry, 5326-5339.

@article{7566519c52e84c538ea222b8b2732a3a,

title = "Synthesis and preclinical characterization of 1-(60-deoxy-60-[18F]fluoro-b-D-allofuranosyl)-2-nitroimidazole (b-60-[18F]FAZAL) as a positron emission tomography radiotracer to assess tumor hypoxia",

author = "Thomas Wanek and Katharina Kreis and Petra Krizkova and Anna Schweifer and Christoph Denk and Johann Stanek and Severin Mairinger and Thomas Filip and Michael Sauberer and Edelhofer, {Patricia Alexandra} and Alexander Traxl and Viktoria Muchitsch and Kurt Mereiter and Friedrich Hammerschmidt and Carol Cass and Vijaya Damaraju and Oliver Langer and Claudia Kuntner",

year = "2016",

language = "English",

pages = "5326--5339",

journal = "Bioorganic and Medicinal Chemistry",

issn = "0968-0896",

publisher = "Elsevier Ltd.",

}

Wanek, T, Kreis, K, Krizkova, P, Schweifer, A, Denk, C, Stanek, J, Mairinger, S, Filip, T, Sauberer, M, Edelhofer, PA, Traxl, A, Muchitsch, V, Mereiter, K, Hammerschmidt, F, Cass, C, Damaraju, V, Langer, O & Kuntner, C 2016, 'Synthesis and preclinical characterization of 1-(60-deoxy-60-[18F]fluoro-b-D-allofuranosyl)-2-nitroimidazole (b-60-[18F]FAZAL) as a positron emission tomography radiotracer to assess tumor hypoxia', Bioorganic and Medicinal Chemistry, pp. 5326-5339.

Synthesis and preclinical characterization of 1-(60-deoxy-60-[18F]fluoro-b-D-allofuranosyl)-2-nitroimidazole (b-60-[18F]FAZAL) as a positron emission tomography radiotracer to assess tumor hypoxia. / Wanek, Thomas; Kreis, Katharina; Krizkova, Petra et al.
In: Bioorganic and Medicinal Chemistry, 2016, p. 5326-5339.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Synthesis and preclinical characterization of 1-(60-deoxy-60-[18F]fluoro-b-D-allofuranosyl)-2-nitroimidazole (b-60-[18F]FAZAL) as a positron emission tomography radiotracer to assess tumor hypoxia

AU - Wanek, Thomas

AU - Kreis, Katharina

AU - Krizkova, Petra

AU - Schweifer, Anna

AU - Denk, Christoph

AU - Stanek, Johann

AU - Mairinger, Severin

AU - Filip, Thomas

AU - Sauberer, Michael

AU - Edelhofer, Patricia Alexandra

AU - Traxl, Alexander

AU - Muchitsch, Viktoria

AU - Mereiter, Kurt

AU - Hammerschmidt, Friedrich

AU - Cass, Carol

AU - Damaraju, Vijaya

AU - Langer, Oliver

AU - Kuntner, Claudia

PY - 2016

Y1 - 2016

M3 - Article

SN - 0968-0896

SP - 5326

EP - 5339

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

ER -